NCT04600089View on ClinicalTrials.gov

Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 8, 2020

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Descending Aortic DissectionPostoperative PainThoracoabdominal Aortic Aneurysm
Interventions
DRUG

Saline

Saline infusion

DRUG

Ketamine

Continuous ketamine infusion at a dose of 0.2 mg/kg/hr, initiated at the induction of anesthesia and continued for 48 hours postoperatively.

Trial Locations (1)

40536

RECRUITING

University of Kentucky Medical Center, Lexington

All Listed Sponsors
lead

Sam Tyagi

OTHER